Erythropoietin requires endothelial nitric oxide synthase to counteract TNF-α-induced microcirculatory dysfunction in murine striated muscle

Shock

Volumn 35, Issue 3, 2011, Pages 315-321

  Contaldo, Claudio ^a   Lindenblatt, Nicole ^a   Elsherbiny, Ahmed ^a   Högger, Dominik C ^a   Borozadi, Meisam Khorrami ^a   Vetter, Sebastian T ^a   Lang, Karl S ^b   Handschin, Alexander E ^a   Giovanoli, Pietro ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b INSTITUTE OF EXPERIMENTAL IMMUNOLOGY   (Switzerland)

Author keywords

apoptosis; functional capillary density; Intravital microscopy; leukocyte endothelial interaction; NO synthase

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; RECOMBINANT ERYTHROPOIETIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CELL ADHESION; CONTROLLED STUDY; DRUG EFFECT; ENZYME PHOSPHORYLATION; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LEUKOCYTE ACTIVATION; MACROPHAGE; MALE; MICROCIRCULATION; MICROVASCULAR ISCHEMIA; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SKELETAL MUSCLE;

ANIMALS; APOPTOSIS; ERYTHROPOIETIN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICROCIRCULATION; MICROSCOPY, FLUORESCENCE; MUSCLE, STRIATED; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79952168680     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3181fd0700     Document Type: Article

References (35)

1. Fisher JW: Erythropoietin: physiology and pharmacology update. Exp Biol Med 228:1-14, 2003. (Pubitemid 36077622)
2. Brines M, Cerami A: Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response. J Intern Med 264:405-432, 2008.
3. Dangerfield JP, Wang S, Nourshargh S: Blockade of alpha6 integrin inhibits IL-1beta-but not TNF-alpha-induced neutrophil transmigration in vivo. J Leukoc Biol 77:159-165, 2005. (Pubitemid 40315049)
4. Munoz C, Carlet J, Fitting C, Misset B, Blériot JP, Cavaillon JM: Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest 88:1747-1754, 1991.
5. Weber C: Novel mechanistic concepts for the control of leukocyte transmigration: specialization of integrins, chemokines, and junctional molecules. J Mol Med 81:4-19, 2003. (Pubitemid 36207879)
6. Fiedler U, Reiss Y, Scharpfenecker M, Grunow V, Koidl S, Thurston G, Gale NW, Witzenrath M, Rosseau S, Suttorp N, et al.: Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat Med 12:235-239, 2006. (Pubitemid 43214752)
7. Villa P, Bigini P, Mennini T, Agnello D, Laragione T, Cagnotto A, Viviani B, Marinovich M, Cerami A, Coleman TR, et al.: Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J Exp Med 198:971-975, 2003. (Pubitemid 37152934)
8. Viviani B, Bartesaghi S, Corsini E, Villa P, Ghezzi P, Garau A, Galli CL, Marinovich M: Erythropoietin protects primary hippocampal neurons increasing the expression of brain-derived neurotrophic factor. J Neurochem 93:412-421, 2005. (Pubitemid 40547498)
9. Khurana VG, Smith LA, Baker TA, Eguchi D, O'Brien T, Katusic ZS: Protective vasomotor effects of in vivo recombinant endothelial nitric oxide synthase gene expression in a canine model of cerebral vasospasm. Stroke 33:782-789, 2002. (Pubitemid 34204007)
10. Joyeux-Faure M, Ramond A, Béguin PC, BelaBdi E, Godin-Ribuot D, Ribuot C: Early pharmacological preconditioning by erythropoietin mediated by inducible NOS and mitochondrial ATP-dependent potassium channels in the rat heart. Fundam Clin Pharmacol 20:51-56, 2006.
11. d'Uscio LV, Smith LA, Santhanam AV, Richardson D, Nath KA, Katusic ZS: Essential role of endothelial nitric oxide synthase in vascular effects of erythropoietin. Hypertension 49: 1142-1148, 2007. (Pubitemid 351664320)
12. Contaldo C, Elsherbiny A, Lindenblatt N, Plock JA, Trentz O, Giovanoli P, Menger MD, Wanner GA: Erythropoietin enhances oxygenation in critically perfused tissue through modulation of nitric oxide synthase. Shock 31:599-606, 2009.
13. Baker M, Wayland H: On-line volume flow rate and velocity profile measurement for blood in microvessels. Microvasc Res 7:131-143, 1974.
14. Contaldo C, Meier C, Elsherbiny A, Harder Y, Trentz O, Menger MD, Wanner GA: Human recombinant erythropoietin protects the striated muscle microcirculation of the dorsal skinfold from postischemic injury in mice. Am J Physiol Heart Circ Physiol 293:H274-H283, 2007. (Pubitemid 47105082)
15. Amon M, Menger MD, Vollmar B: Heme oxygenase and nitric oxide synthase mediate cooling-associated protection against TNF-alpha-induced microcirculatory dysfunction and apoptotic cell death. FASEB J 17:175-185, 2003. (Pubitemid 36164387)
16. Wu H, Lee SH, Gao J, Liu X, Iruela-Arispe ML: Inactivation of erythropoietin leads to defects in cardiac morphogenesis. Development 126:3597-3605, 1999. (Pubitemid 29419516)
17. Kertesz N, Wu J, Chen TH, Sucov HM, Wu H: The role of erythropoietin in regulating angiogenesis. Dev Biol 276:101-110, 2004. (Pubitemid 39452849)
18. Anagnostou A, Lee ES, Kessimian N, Levinson R, Steiner M: Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc Natl Acad Sci U S A 87:5978-5982, 1990.
19. Heeschen C, Aicher A, Lehmann R, Fichtlscherer S, Vasa M, Urbich C, Mildner-Rihm C, Martin H, Zeiher AM, Dimmeler S: Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 102:1340-1346, 2003. (Pubitemid 36988041)
20. Santhanam AV, Smith LA, Nath KA, Katusic ZS: In vivo stimulatory effect of erythropoietin on endothelial nitric oxide synthase in cerebral arteries. Am J Physiol Heart Circ Physiol 291:H781-H786, 2006. (Pubitemid 44175085)
21. Bührer C, Felderhoff-Mueser U, Wellmann S: Erythropoietin and ischemic conditioning-why two good things may be bad. Acta Paediatr 96:787-789, 2007. (Pubitemid 46846920)
22. Urao N, Okigaki M, Yamada H, Aadachi Y, Matsuno K, Matsui A, Matsunaga S, Tateishi K, Nomura T, Takahashi T, et al.: Erythropoietin-mobilized endothelial progenitors enhance reendothelialization via Akt-endothelial nitric oxide synthase activation and prevent neointimal hyperplasia. Circ Res 98: 1405-1413, 2006. (Pubitemid 43948065)
23. Worthylake RA, Burridge K: Leukocyte transendothelial migration: orchestrating the underlying molecular machinery. Curr Opin Cell Biol 13:569-577, 2001. (Pubitemid 32817015)
24. Liu P, Xu B, Hock CE, Nagele R, Sun FF, Wong PY: NO modulates P-selectin and ICAM-1 mRNA expression and hemodynamic alterations in hepatic I/R. Am J Physiol 275:H2191-H2198, 1998.
25. Qian H, Neplioueva V, Shetty GA, Channon KM, George SE: Nitric oxide synthase gene therapy rapidly reduces adhesion molecule expression and inflammatory cell infiltration in carotid arteries of cholesterol-fed rabbits. Circulation 99:2979-2982, 1999. (Pubitemid 29270425)
26. Beleslin-Cokic BB, Cokic VP, Yu X, Weksler BB, Schechter AN, Noguchi CT: Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production by endothelial cells. Blood 104:2073-2080, 2004. (Pubitemid 39297859)
27. Kubes P, Kanwar S, Niu XF, Gaboury JP: Nitric oxide synthesis inhibition induces leukocyte adhesion via superoxide and mast cells. FASEB J 7: 1293-1299, 1993. (Pubitemid 23314366)
28. Kao R, Xenocostas A, Rui T, Yu P, Huang W, Rose J, Martin CM: Erythropoietin improves skeletal muscle microcirculation and tissue bioenergetics in a mouse sepsis model. Crit Care 11:R58, 2007.
29. Jerome SN, Smith CW, Korthuis RJ: CD18-dependent adherence reactions play an important role in the development of the no-reflow phenomenon. Am J Physiol 264:H479-H483, 1993. (Pubitemid 23081121)
30. Granger DN, Kubes P: The microcirculation and inflammation: modulation of leukocyte-endothelial cell adhesion. J Leukoc Biol 55:662-675, 1994. (Pubitemid 24171735)
31. Brines M, Cerami A: Emerging biological roles for erythropoietin in the nervous system. Nat Rev Neurosci 6:484-494, 2005. (Pubitemid 40769173)
32. Dimmeler S, Zeiher AM: Nitric oxide and apoptosis: another paradigm for the double-edged role of nitric oxide. Nitric Oxide 1:275-281, 1997. (Pubitemid 28078114)
33. Mannick JB, Asano K, Izumi K, Kieff E, Stamler JS: Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell 79:1137-1146, 1994.
34. Mannick JB, Miao XQ, Stamler JS: Nitric oxide inhibits Fas-induced apoptosis. J Biol Chem 272:24125-24128, 1997. (Pubitemid 27418605)
35. Thomas SR, Chen K, Keaney JF Jr: Hydrogen peroxide activates endothelial nitric-oxide synthase through coordinated phosphorylation and dephosphorylation via a phosphoinositide 3-kinase-dependent signaling pathway. J Biol Chem 277:6017-6124, 2001.